Krka Stock

PLN848.00

0.47% day before yesterday

Warsaw, Jul 18, 04:44 pm CET

ISIN

SI0031102120

Symbol

KRK

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts Strategies

Krka Stock price

PLN848.00

+458.00 117.44% 5Y

Warsaw, Closing price Fri, Jul 18 2025

-4.00 0.47%

ISIN

SI0031102120

Symbol

KRK

Sector

Health

Industry

Pharmaceuticals

Key metrics

Basic

Market capitalization

PLN38.6b

Enterprise Value

PLN56.8b

Net debt

PLN18.2b

Cash

PLN68.1b

Shares outstanding

2.5b

Valuation (TTM | estimate)

P/E

- | 346.6

P/S

0.1 | 0.2

EV/Sales

0.2 | 0.2

EV/FCF

negative

P/B

0.7

Dividends

DPS

PLN32.09

Yield 1Y | 5Y

3.8% | 4.9%

Growth 1Y | 5Y

100.0% | -

Payout 1Y | 3Y

0.0% | 1,217.1%

Increased

1 Year

Financials (TTM | estimate)

Revenue

PLN258.4b | PLN252.6b

EBITDA

PLN14.2b | PLN21.9b

EBIT

PLN8.4b | PLN16.8b

Net Income

PLN-9.9m | PLN6.2b

Free Cash Flow

PLN-8.7b

Growth (TTM | estimate)

Revenue

52.8% | 20.5%

EBITDA

-34.4% | 169.2%

EBIT

-54.5% | 186.2%

Net Income

-100.2% | 5,149.7%

Free Cash Flow

-4.7%

Financial Health

Equity Ratio

13.5%

Return on Equity

0.3%

ROCE

6.5%

ROIC

-1.8%

Debt/Equity

1.7

EPS

PLN0.0

FCF per Share

PLN-3.4

Short interest

Employees

131k

Rev per Employee

PLN1.6m

As a Free StocksGuide user, you can view scores for all 7,009 stocks worldwide.

Get Started for Free Today

Krka Stock Analysis

Unlock Scores for Free

??

13 Analysts have issued a Krka forecast:

12x Buy

92%

More details on Analyst Estimates Including Price Targets

13 Analysts have issued a Krka forecast:

Buy

92%

Hold

Analyst Estimates with Stock Price Targets

Financial data from Krka

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Mar '25		+/- %
Revenue	258,380 258,380	53% 53% 100%
- Direct Costs	220,393 220,393	66% 66% 85%
Gross Profit	37,987 37,987	5% 5% 15%
- Selling and Administrative Expenses	29,722 29,722	67% 67% 12%
- Research and Development Expense	792 792	119% 119% 0%
EBITDA	14,224 14,224	34% 34% 6%
- Depreciation and Amortization	5,869 5,869	76% 76% 2%
EBIT (Operating Income) EBIT	8,355 8,355	54% 54% 3%
Net Profit	-9.86 -9.86	100% 100% 0%

In millions PLN.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Company Profile

KRKA dd is a generic pharmaceutical company, which engages in the development, production, marketing, and sale of human and animal health products. It operates through the following geographical segments: European Union, South-East Europe, Eastern Europe, and Other. The European Union segment includes all countries of the European Union. The South-East Europe segment consists of Serbia, Bosnia and Herzegovina, Macedonia, Montenegro, Kosovo, and Albania. The Eastern Europe segment comprises of the Russian Federation and other former Soviet Union countries, excluding the Baltic countries. The company was founded by Boris Andrijanic in 1954 and is headquartered in Novo Mesto, Slovenia.

Head office	Slovenia
CEO	Jože Colaric
Employees	130,760
Founded	1954
Website	www.koc.com.tr

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now